1. Home
  2. FGEN vs GROV Comparison

FGEN vs GROV Comparison

Compare FGEN & GROV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • FGEN
  • GROV
  • Stock Information
  • Founded
  • FGEN 1993
  • GROV 2016
  • Country
  • FGEN United States
  • GROV United States
  • Employees
  • FGEN N/A
  • GROV N/A
  • Industry
  • FGEN Biotechnology: Pharmaceutical Preparations
  • GROV Package Goods/Cosmetics
  • Sector
  • FGEN Health Care
  • GROV Consumer Discretionary
  • Exchange
  • FGEN Nasdaq
  • GROV Nasdaq
  • Market Cap
  • FGEN 45.0M
  • GROV 53.5M
  • IPO Year
  • FGEN 2014
  • GROV N/A
  • Fundamental
  • Price
  • FGEN $11.16
  • GROV $1.50
  • Analyst Decision
  • FGEN Strong Buy
  • GROV Buy
  • Analyst Count
  • FGEN 2
  • GROV 2
  • Target Price
  • FGEN $146.50
  • GROV $1.35
  • AVG Volume (30 Days)
  • FGEN 30.7K
  • GROV 47.8K
  • Earning Date
  • FGEN 11-11-2025
  • GROV 11-11-2025
  • Dividend Yield
  • FGEN N/A
  • GROV N/A
  • EPS Growth
  • FGEN N/A
  • GROV N/A
  • EPS
  • FGEN N/A
  • GROV N/A
  • Revenue
  • FGEN $7,346,000.00
  • GROV $185,354,000.00
  • Revenue This Year
  • FGEN N/A
  • GROV N/A
  • Revenue Next Year
  • FGEN N/A
  • GROV $11.10
  • P/E Ratio
  • FGEN N/A
  • GROV N/A
  • Revenue Growth
  • FGEN N/A
  • GROV N/A
  • 52 Week Low
  • FGEN $4.50
  • GROV $1.02
  • 52 Week High
  • FGEN $21.94
  • GROV $1.95
  • Technical
  • Relative Strength Index (RSI)
  • FGEN 46.07
  • GROV 49.32
  • Support Level
  • FGEN $11.36
  • GROV $1.48
  • Resistance Level
  • FGEN $12.13
  • GROV $1.55
  • Average True Range (ATR)
  • FGEN 0.54
  • GROV 0.05
  • MACD
  • FGEN -0.20
  • GROV -0.00
  • Stochastic Oscillator
  • FGEN 8.97
  • GROV 54.55

About FGEN FibroGen Inc

FibroGen Inc is a biotechnology company focused on discovering, developing, and commercializing novel therapeutics to treat serious cancer biology and anemia. The company operates in one reportable segment: the development and commercialization of novel therapeutics to treat serious unmet medical needs. The company generates the vast majority of its revenue in Europe, followed by Japan. Virtually all of FibroGen's revenue to date has been generated from its collaboration agreements. FibroGen seeks partners with research, development, and marketing capabilities and other resources that strengthen the company's ability to advance product candidates. Geographically, it operates in United States, Japan, Europe and Others.

About GROV Grove Collaborative Holdings Inc.

Grove Collaborative Holdings Inc is engaged in providing consumer products. It offers Cleaning accessories, Home and Pantry, Personal care products, Pets supplements and Other products. It is a sustainability oriented consumer products generator. It use connection with consumers to create and curate authentic, disruptive brands and products. Company builds natural products that perform as well as, many consumer packaged goods (CPG) brands (both conventional and natural), while being healthier for consumers and the planet.

Share on Social Networks: